AstraZeneca (LON:AZN) is looking for final year MD or PhD students and postdoctoral researchers to reach out with ideas to speed drug discovery and development in the company’s core disease areas.
The company’s central focus areas include oncology; cardiovascular, renal and metabolism; and respiratory and immunology.
Candidates accepted into the program have a fully funded postdoctoral research position that gives them access to in-house expertise, access to AstraZeneca’s R&D facilities and support from a partnering university.
Researchers will also get access to compounds, tools and technologies and mentoring.
Sir Mene Pangalos, AstraZeneca’s executive vice president, biopharmaceuticals R&D highlighted the need to continue accelerating R&D. “Rapid progress in disease understanding, as well as scientific and technological advances are genuinely changing our expectations of what is possible,” Pangalos said. “We are delighted to launch the R&D Postdoctoral Challenge to support the next generation of science leaders and help them translate their ideas into meaningful benefits for patients.”
Applicants who are shortlisted will receive an opportunity to pitch research proposals to a judging panel.